We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Defensins Protect Against HIV Infection

By Biotechdaily staff writers
Posted on 06 Nov 2003
Researchers have found that beta defensins 2 and 3 (hBD2 and hBD3), peptides produced by oral mucosal tissue, protect the mouth from infection by the AIDS virus by binding directly to the viral particles and by regulating receptors the virus requires to infect human cells.

Investigators from Case Western Reserve University (Cleveland, OH, USA; www.cwru.edu) and the Cleveland Clinic (OH, USA; www.clevelandclinic.org) studied the interaction of HIV-1 with human oral mucosal cells being grown in tissue culture. More...
They found that HIV-1 induced expression of hBD-2 and -3 mRNA (but not that of hBD-1) four- to 78-fold, respectively, above baseline in normal human oral epithelial cells. The virus failed to infect these cells even after five days of exposure. Recombinant hBD-1 had no antiviral activity, while rhBD-2 and rhBD-3 showed concentration-dependent inhibition of HIV-1 replication without cellular toxicity. These findings were published in the November 7, 2003, edition of AIDS.

"It is the unique properties of the good bugs found in the mouth that are inducing the expression of hBD2 and 3,” explained senior author Dr. Aaron Weinberg, director of research at the Case Western Reserve University School of Dentistry. "Information gained from the study has the potential to develop new medical interventions using natural products, such as those being isolated from the ‘good oral bugs' that induce hBD2 and 3, in other sites of the body that are more susceptible to HIV infection.”





Related Links:
Case Western Reserve University
Cleveland Clinic

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.